Tirzepatide 5mg
£41.00 Original price was: £41.00.£39.90Current price is: £39.90.
- Each vial contains Tirzepatide 5mg, a synthetic peptide-based medication that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide is primarily researched for its potent effects on glucose regulation, insulin sensitivity, and weight management. It is believed to work by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, leading to improved blood sugar control and reduced appetite. Tirzepatide is being studied for potential applications in type 2 diabetes, obesity, metabolic syndrome, and related cardiovascular risk reduction.
Description
- Each vial contains Tirzepatide 5mg, a synthetic peptide-based compound that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Tirzepatide is primarily researched for its ability to regulate blood sugar levels, enhance insulin sensitivity, and support weight management. It works by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying, thereby improving metabolic balance and promoting satiety.
Tirzepatide is a novel peptide that mimics the actions of both GIP and GLP-1, two naturally occurring incretin hormones involved in glucose and energy regulation. This dual activity allows Tirzepatide to improve glycemic control while supporting healthy body weight management. It is being extensively researched for its potential use in type 2 diabetes and obesity.
Supports healthy blood glucose regulation
Enhances insulin sensitivity and secretion
Reduces glucagon levels to lower excess glucose production
Promotes weight reduction by decreasing appetite and caloric intake
May support metabolic and cardiovascular health
Tirzepatide works through dual receptor activation, targeting both GIP and GLP-1 pathways to optimize metabolic function. Its mechanisms include:
Stimulating insulin release in response to elevated glucose levels
Suppressing glucagon secretion, which helps lower blood sugar
Delaying gastric emptying to promote fullness and reduce appetite
Enhancing lipid metabolism, contributing to improved overall energy balance
Tirzepatide represents a next-generation metabolic therapy, combining the benefits of two incretin pathways into a single molecule. Through its multifaceted effects on glucose control, appetite, and energy balance, it shows promising potential for supporting metabolic health, weight management, and overall wellness.
- Intended for laboratory research purposes only
- Not for human use or consumption
- Check local laws and regulations before ordering or handling
Additional information
| Brand |
KLÖBER |
|---|

Reviews
There are no reviews yet.